MetLife Investment Management LLC Makes New Investment in SPDR S&P Biotech ETF $XBI

MetLife Investment Management LLC bought a new position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 1,925 shares of the exchange traded fund’s stock, valued at approximately $156,000.

Several other institutional investors and hedge funds have also added to or reduced their stakes in the stock. RPg Family Wealth Advisory LLC lifted its stake in SPDR S&P Biotech ETF by 11.8% in the 1st quarter. RPg Family Wealth Advisory LLC now owns 20,013 shares of the exchange traded fund’s stock valued at $1,623,000 after purchasing an additional 2,109 shares during the last quarter. Jump Financial LLC bought a new position in SPDR S&P Biotech ETF in the 1st quarter valued at approximately $25,215,000. SVB Wealth LLC bought a new position in SPDR S&P Biotech ETF in the 1st quarter valued at approximately $109,000. Q Global Advisors LLC bought a new position in SPDR S&P Biotech ETF in the 1st quarter valued at approximately $811,000. Finally, RPG Investment Advisory LLC lifted its stake in SPDR S&P Biotech ETF by 98.0% in the 1st quarter. RPG Investment Advisory LLC now owns 50,740 shares of the exchange traded fund’s stock valued at $4,115,000 after purchasing an additional 25,109 shares during the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of NYSEARCA:XBI opened at $94.98 on Wednesday. The company has a market cap of $5.17 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97. The firm has a 50 day simple moving average of $88.29 and a 200 day simple moving average of $83.91. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $105.47.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.